General clinical parameters of GBM TS-matched patients, including age, sex, MGMT methylation, EGFR amplification, Ki-67 expression, and extent of resection (EOR), were not significantly correlated with the invasiveness of GBM TSs (Supplementary Fig. S2). This evidence concerns the gene EGFR and glioblastoma.